X Bioscience PCL (BKK:XBIO)
Thailand · Delayed Price · Currency is THB 0.0700
-0.0100 (-12.50%)
At close: Feb 10, 2026
X Bioscience PCL Cash Flow Statement
Financials in millions THB. Fiscal year is January - December.
Millions THB. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Net Income | -396.15 | -260.22 | -147.52 | -575.99 | -276.45 | -238.81 |
Depreciation & Amortization | 48.4 | 65.35 | 46.04 | 143.95 | 118.78 | 91.26 |
Other Amortization | 1.94 | 1.94 | 0.57 | 2.27 | 1.28 | 0.57 |
Loss (Gain) From Sale of Assets | -18.82 | -0.3 | 0 | 98.28 | 0.26 | 119.05 |
Asset Writedown & Restructuring Costs | 249.57 | 100.21 | 25.06 | 86.78 | 4.52 | -19.37 |
Loss (Gain) From Sale of Investments | - | - | - | - | - | -0.04 |
Provision & Write-off of Bad Debts | 6.99 | 6.99 | - | - | - | -3.07 |
Other Operating Activities | 7.23 | -11.03 | 8.22 | 10.3 | 190.49 | 24.68 |
Change in Accounts Receivable | 21.61 | 21.17 | -3.12 | -9.72 | -10.28 | 2.84 |
Change in Inventory | -0.27 | -4.5 | 6.33 | -6.61 | -14.88 | -24.07 |
Change in Accounts Payable | 8.79 | 38.31 | -3.82 | 100.5 | 35.27 | 19.75 |
Change in Other Net Operating Assets | 11.63 | 4.64 | -8.06 | -2.16 | -11.58 | -2.91 |
Operating Cash Flow | -59.07 | -37.44 | -76.31 | -152.41 | -139.13 | -30.11 |
Capital Expenditures | -14.45 | -36.33 | -57.28 | -138.81 | -73.43 | -37.47 |
Sale of Property, Plant & Equipment | 0.76 | 2.11 | 4.1 | 3.51 | 0.06 | 0.26 |
Cash Acquisitions | -453.15 | -445.01 | - | - | - | -314.52 |
Divestitures | 14.79 | - | - | 267.06 | - | 61.82 |
Investment in Securities | 70 | - | - | - | - | 10 |
Other Investing Activities | 0.64 | -0.25 | - | -0.2 | -0.6 | -0.22 |
Investing Cash Flow | -381.4 | -479.47 | -53.18 | 131.56 | -73.97 | -345.97 |
Short-Term Debt Issued | - | 28.06 | 260.5 | 517.45 | 294.59 | 144.49 |
Long-Term Debt Issued | - | - | - | - | 6 | 10.55 |
Total Debt Issued | 36.33 | 28.06 | 260.5 | 517.45 | 300.59 | 155.04 |
Short-Term Debt Repaid | - | -76.9 | -311.26 | -456.22 | -66.49 | -99.87 |
Long-Term Debt Repaid | - | -42.64 | -36.93 | -59.14 | -36.49 | -15.5 |
Total Debt Repaid | -25.31 | -119.54 | -348.19 | -515.36 | -102.97 | -115.36 |
Net Debt Issued (Repaid) | 11.03 | -91.48 | -87.69 | 2.09 | 197.61 | 39.68 |
Issuance of Common Stock | 428.68 | 590.84 | 227.78 | - | 0 | 338.09 |
Other Financing Activities | - | - | - | 6.9 | - | - |
Financing Cash Flow | 439.71 | 499.36 | 140.09 | 8.99 | 197.61 | 377.77 |
Foreign Exchange Rate Adjustments | - | - | - | - | - | 0.36 |
Miscellaneous Cash Flow Adjustments | - | - | - | - | 0.09 | - |
Net Cash Flow | -0.77 | -17.56 | 10.59 | -11.86 | -15.4 | 2.04 |
Free Cash Flow | -73.52 | -73.77 | -133.59 | -291.22 | -212.57 | -67.58 |
Free Cash Flow Margin | -35.93% | -23.11% | -42.85% | -84.54% | -83.67% | -16.26% |
Free Cash Flow Per Share | -0.26 | -0.40 | -1.07 | -2.50 | -1.83 | -0.70 |
Cash Interest Paid | 17.94 | 18.99 | 30.47 | 48.17 | 3.55 | 1.74 |
Levered Free Cash Flow | -558.26 | -148.08 | -99.45 | -202.98 | -1.21 | 234.37 |
Unlevered Free Cash Flow | -541.3 | -126.65 | -74.48 | -167.66 | 7.82 | 244.73 |
Change in Working Capital | 41.76 | 59.61 | -8.67 | 82.01 | -1.47 | -4.39 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.